Biora Therapeutics, Inc. (BIOR) has announced a reverse stock split that will take effect on October 18, 2024. The reverse split will be conducted at a ratio of 1-for-10, meaning that shareholders will receive one new share of Biora Therapeutics for every ten shares they currently hold. Following the split, the company's stock symbol on the market will change from BIOR to BIOR1. The new CUSIP number for Biora Therapeutics will be 74319F404. The pricing for the new BIOR1 symbol will be determined by multiplying the BIOR price by 0.10. The reverse stock split will also result in a new contract multiplier of 100 for options and a new deliverable per contract of 10 new common shares of Biora Therapeutics. This corporate event is expected to affect listed options and futures, with adjustments made by the Options Clearing Corporation (OCC) in accordance with their by-laws.

Biora Therapeutics, Inc. (BIOR) has announced a reverse stock split that will take effect on October 18, 2024. The reverse split will be conducted at a ratio of 1-for-10, meaning that shareholders will receive one new share of Biora Therapeutics for every ten shares they currently hold. Following the split, the company's stock symbol on the market will change from BIOR to BIOR1. The new CUSIP number for Biora Therapeutics will be 74319F404. The pricing for the new BIOR1 symbol will be determined by multiplying the BIOR price by 0.10. The reverse stock split will also result in a new contract multiplier of 100 for options and a new deliverable per contract of 10 new common shares of Biora Therapeutics. This corporate event is expected to affect listed options and futures, with adjustments made by the Options Clearing Corporation (OCC) in accordance with their by-laws.